Advanced in Prostate Cancer

Dr. James A. Wheeler

Radiation Oncology
Goshen Health System Inc
2824 Elkhart Rd, Goshen Physicians Diagnost, 
Goshen, IN 
Accepting New Patients
37 Years of Experience
Advanced in Prostate Cancer
Goshen Health System Inc
2824 Elkhart Rd, Goshen Physicians Diagnost, 
Goshen, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Wheeler is a Radiation Oncologist in Goshen, Indiana. Dr. Wheeler has been practicing medicine for over 37 years and is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Wheeler is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Prostate Cancer.

Graduate Institution
University Of Kansas School Of Med (Kc/wich/sal), 1989
Specialties
Radiation Oncology
Licenses
Radiology in IN
Hospital Affiliations
Goshen Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO

Locations

GOSHEN HEALTH SYSTEM INC
2824 Elkhart Rd, Goshen Physicians Diagnost, Goshen, IN 46526
Other Locations
GOSHEN HEALTH SYSTEM INC
200 High Park Ave, Goshen, IN 46526

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

5 Total Publications

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 17, 2019
Similar Doctors
Distinguished in Prostate Cancer
Dr. Jeffrey J. Quackenbush
Radiation Oncology
Distinguished in Prostate Cancer
Dr. Jeffrey J. Quackenbush
Radiation Oncology
85 E Us Hwy 6 100, Porter Radiation Oncology, 
Valparaiso, IN 
 (60.8 miles away)
219-983-6100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeffrey Quackenbush is a Radiation Oncologist in Valparaiso, Indiana. Dr. Quackenbush is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Astrocytoma. Dr. Quackenbush is currently accepting new patients.

Distinguished in Prostate Cancer
Dr. Mazen Mislmani
Radiation Oncology
Distinguished in Prostate Cancer
Dr. Mazen Mislmani
Radiation Oncology

West Michigan Cancer Center

200 N Park St, 
Kalamazoo, MI 
 (49.7 miles away)
269-373-7488
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mazen Mislmani is a Radiation Oncologist in Kalamazoo, Michigan. Dr. Mislmani is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Adult Soft Tissue Sarcoma. Dr. Mislmani is currently accepting new patients.

Distinguished in Prostate Cancer
Dr. Charles T. Vu
Radiation Oncology
Distinguished in Prostate Cancer
Dr. Charles T. Vu
Radiation Oncology

Radiation Oncology Associates P C

7910 W Jefferson Blvd, Suite 110, 
Fort Wayne, IN 
 (51.0 miles away)
260-436-4116
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Charles Vu is a Radiation Oncologist in Fort Wayne, Indiana. Dr. Vu is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Laryngeal Cancer. Dr. Vu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wheeler's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile